Litfulo 50 mg/1
ritlecitinib · CAPSULE · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Litfulo is a capsule containing ritlecitinib at 50 mg/1, taken oral. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Litfulo
- Generic Name
- ritlecitinib
- NDC Code (Product)
0069-0334- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 50 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA215830
- Marketing Start
- 07/06/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Litfulo used for?
Litfulo contains ritlecitinib. It is a capsule taken oral. Consult your doctor for specific uses.
Is Litfulo a controlled substance?
Litfulo is not classified as a controlled substance by the DEA.
What is the generic name for Litfulo?
The generic name for Litfulo is ritlecitinib. There are no other listed brand versions of ritlecitinib.
What is the NDC code for Litfulo 50 mg/1?
The NDC (National Drug Code) for Litfulo 50 mg/1 is 0069-0334, listed by Pfizer Laboratories Div Pfizer Inc.
Other Litfulo Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)